Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

Clinical Trial ID NCT00099762

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00099762

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000 7.41
2 FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 2001 1.90
3 Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003 1.42
Next 100